Agenus Inc.
ANTI-CTLA-4 ANTIBODIES AND METHODS OF USE THEREOF

Last updated:

Abstract:

The instant disclosure provides antibodies that specifically bind to human CTLA-4 and antagonize CTLA-4 function. Also provided are pharmaceutical compositions comprising these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for making these antibodies, and methods of treating a subject using these antibodies.

Status:
Application
Type:

Utility

Filling date:

24 Jan 2022

Issue date:

25 Aug 2022